iNtRON Biotechnology, Inc. (KOSDAQ: A048530)
Health Care · Biotechnology · KR
₩2,785.00
-2.11% today · -24.3% 1Y
iNtRON Biotechnology, Inc. (KOSDAQ: A048530) operates in the Biotechnology industry within the Health Care sector. The company is valued at $64.53M.
Over the last twelve months the share price has lost 24.3%, trading between 2.25K and 7.01K.
Tweenvest scores iNtRON Biotechnology, Inc. across four factors: quality 55/100, value 58/100, growth 0/100. Its strongest factor is value.
A048530 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $64.53M
- Revenue (TTM)
- $3.98M
- P/E
- —
- EPS
- -282.94
- Dividend yield
- —
- Beta (5Y)
- 0.10
- 52-week high
- ₩7,010.00
- 52-week low
- ₩2,250.00
- Avg volume (3M)
- —
- Shares outstanding
- 30.89M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| StemRIMTSE: 4599 | $65.11M | ¥164.00 | -6.29% |
| CORESTEMCHEMON Inc.KOSDAQ: A166480 | $64.85M | ₩1,949.00 | -16.71% |
| Spero Therapeutics, Inc.NasdaqGS: SPRO | $64.64M | $1.11 | -1.77% |
| XBiotech Inc.NasdaqGS: XBIT | $64.63M | $2.12 | -7.42% |
| Fortress Biotech, Inc.NasdaqCM: FBIO | $64.37M | $1.93 | -3.02% |
| Oncolytics Biotech Inc.NasdaqCM: ONCY | $63.51M | $0.50 | -10.57% |
| EyeGene Inc.KOSDAQ: A185490 | $63.26M | ₩1,951.00 | +4.33% |
| Nuo Therapeutics, Inc.OTCPK: AURX | $62.96M | $1.30 | +4.00% |
Figures last refreshed Oct 18, 2026.